Also, decreased FAS expression may protect transformed cells from being eliminated by anti-tumor immune responses, whereas heightened FASL expression may increase the ability of tumor cells to counter-attack the immune system by killing FAS-sensitive lymphocytes, contributing to cancer development [13]. The gene discussed is FASLG; the disease is cancer.